远翔新材 reported revenue of ¥0.25B for the period ended 2026-06-30, +4.9% year on year. Net income was ¥0.02B, a 9.9% net margin on a 22.8% gross margin. The largest revenue line is 硅橡胶用二氧化硅(通用型) at 86% of the total. Free cash flow for the period was ¥0.02B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.25B | +4.9% |
| Gross profit | ¥0.06B | — |
| Operating income | ¥0.03B | — |
| Net income | ¥0.02B | -39.5% |
| Gross margin | 22.8% | Net margin 9.9% |
| Revenue Q/Q | +8.3% | — |
| Segment | Revenue | Share |
|---|---|---|
| 硅橡胶用二氧化硅(通用型) | ¥0.21B | 86.2% |
| 其他应用二氧化硅 | ¥0.02B | 8.6% |
| 硅橡胶用二氧化硅(高透明型) | ¥0.01B | 4.4% |
| 其他(补充) | ¥0.00B | 0.6% |
| 混炼胶代加工 | ¥0.00B | 0.2% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.19B | 77.2% |
| R&D | ¥0.01B | 3.8% |
| SG&A | ¥0.02B | 8.3% |
| Tax & other | ¥0.01B | 2.2% |
| Item | Amount |
|---|---|
| Total assets | ¥1.03B |
| Total liabilities | ¥0.18B |
| Shareholders' equity | ¥0.85B |
| Equity / assets | 82.4% |
| Operating cash flow | ¥0.03B |
| Capital expenditure | ¥0.01B |
| Free cash flow | ¥0.02B |
| Cash conversion (OCF / net income) | 167% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
川宁生物 ・ 华如科技 ・ 真兰仪表 ・ 朗坤科技 ・ 西测测试 ・ 美利信 ・ 万得凯 ・ 鑫宏业 ・ 昆船智能 ・ 智立方 ・ 凡拓数创 ・ 科瑞思
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies